0D1J
vs
D
DAX Index
0D1J
Over the past 12 months, 0D1J has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +11% growth.
Stocks Performance
0D1J vs DAX Index
Performance Gap
0D1J vs DAX Index
Performance By Year
0D1J vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Quantum Genomics SA
Glance View
Quantum Genomics SA is a biopharmaceutical company, which develops new medication class for cardiovascular disease, such as high blood pressure and heart failure. The company is headquartered in Paris, Ile-De-France and currently employs 7 full-time employees. The company went IPO on 2009-07-28. The firm provides biotechnological and medical research. Its main activity is research and development of new therapies for the treatment of hypertension, BAPAI (Brain Aminopeptidase A Inhibitors). Quantum Genomics SA's activities are oriented in the field of cardiovascular diseases, especially high blood pressure and heart failure. The firm also co-develops products with academic teams, biotechnological research entities, and some of the pharmaceutical and bio-science companies. The firm is involved in four research programs. Quantum Genomics also collaborates with Center for Clinical Investigation 9201 APHP / INSERM of the Georges Pompidou European Hospital in Paris, among others.
